Aliskiren/amlodipine 300/10 mg tablet
Sponsors
Novartis Pharmaceuticals, Novartis
Conditions
HypertensionModerate to Severe Hypertension
Phase 3
Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension
CompletedNCT00739973
Start: 2008-09-30End: 2009-05-31Updated: 2011-06-06
Efficacy and Safety of the Combination of Aliskiren (300 mg) and Amlodipine (10 mg) Compared to Amlodipine (10 mg) Monotherapy in Patients With Moderate to Severe Hypertension
CompletedNCT00841672
Start: 2009-01-31End: 2009-09-30Updated: 2011-07-12